{"data":{"id":614,"lang":"en","title":"Science Corp Raises $230 Million to Bring Vision-Restoring Brain Implant to Market in 2026","summary":"Science Corp raises $230M to commercialize PRIMA, a tiny retinal implant that restored vision in 80% of trial patients, with EU launch expected mid-2026.","category":"science","category_label":"Science","published_at":"2026-03-06T20:04:07Z","updated_at":"2026-03-06T20:04:07Z","url":"https://techtools.cz/tools/news/article/614-science-corp-raises-230-million-to-bring-vision-restoring-brain-implant-to","api_url":"https://techtools.cz/news-api/v1/articles/614?lang=en","markdown_url":"https://techtools.cz/news-api/v1/articles/614.md?lang=en","image_url":"https://d15shllkswkct0.cloudfront.net/wp-content/blogs.dir/1/files/2026/03/Science1.png","word_count":147,"reading_time_minutes":1,"sources":[{"url":"https://techcrunch.com/2026/03/05/science-corp-closes-230m-round-as-it-pushes-to-get-its-brain-implant-to-patients/","domain":"techcrunch.com"},{"url":"https://siliconangle.com/2026/03/05/brain-computer-interface-startup-science-raises-230m/","domain":"siliconangle.com"}],"translation":{"lang":"cs","id":622,"title":"Science Corp získala 230 milionů dolarů na uvedení mozkového implantátu pro obnovu zraku na trh v roce 2026","url":"https://techtools.cz/tools/news/clanek/622-science-corp-ziskala-230-milionu-dolaru-na-uvedeni-mozkoveho-implantatu-pro","api_url":"https://techtools.cz/news-api/v1/articles/622?lang=cs"},"content":"Science Corporation closed a $230 million Series C round led by Lightspeed, Khosla Ventures, and Y Combinator, bringing total funding to $490 million. The startup's flagship product PRIMA is a 2-millimeter retinal implant with 378 pixel-electrodes that works with specialized infrared glasses to restore functional vision in patients with late-stage macular degeneration — the leading cause of blindness.\n\nIn clinical trials across Europe and the US involving 47 patients, 80% demonstrated meaningful improvement in visual acuity and were able to read letters, numbers, and words. Science Corp has submitted a CE mark application and expects EU approval in mid-2026, with an FDA application also in progress.\n\nThe company, founded by former Neuralink co-founder Max Hodak, operates its own fabrication facility in North Carolina and plans to use the new capital to scale manufacturing. Beyond PRIMA, Science Corp is developing Biohybrid, a higher-bandwidth brain-computer interface using electrodes and microLEDs."}}